-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HRbVzNmjt+ahsa3jnCkajtB9AUXRKsxqSmupgS3injvwUocUQm9JU8rLBo2D4wzU yuaeFZNeMR4gMeJdkBUPnA== 0001225208-11-007645.txt : 20110228 0001225208-11-007645.hdr.sgml : 20110228 20110228175901 ACCESSION NUMBER: 0001225208-11-007645 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100806 FILED AS OF DATE: 20110228 DATE AS OF CHANGE: 20110228 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABELE JOHN E CENTRAL INDEX KEY: 0000901430 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 11648051 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 508-650-8000 MAIL ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 4/A 1 doc4a.xml X0303 4/A 2010-08-06 2010-08-10 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901430 ABELE JOHN E ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2010-08-06 4 S 0 0.0000 0.0000 D 13162718.0000 D Common Stock 2010-08-06 4 S 0 50000.0000 5.7375 D 304200.0000 I By LLC Sales reported on this form were transacted pursuant to a 10b5-1 trading plan. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $5.82 to $5.64. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. Common stock held by a limited liability company of which reporting person holds 100% membership interest. This Form 4 is being amended to correct the disposition of shares by the reporting person's limited liability company, pursuant to a 10b5-1 trading plan entered into by the limited liability company, instead of the reporting person. The Form 4s filed by the reporting person subsequent to this Form 4 reflected the over inclusion of 50,000 shares held by the reporting person's limited liability company and the under inclusion of 50,000 shares directly held by the reporting person. abelepoa2011.txt /s/ Theresa R. Boni, Attorney-in-Fact 2011-02-28 EX-24 2 abelepoa2011.txt POWER OF ATTORNEY Know all by these presents, that the undersigned hereby constitutes and appoints each of Vance R. Brown, Theresa R. Boni, Anne M. Thompson, Michelle K. Gewandter and Linda M. Tibbetts, signing singly, the undersigned's true and lawful attorney-in-fact to: (1) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of Boston Scientific Corporation (the "Company"), Forms 3, 4 and 5, and amendments thereto,in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (2) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 or 5 and file such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; (3) execute for and on behalf of the undersigned, in the undersigned's capacity as an executive officer and/or director of the Company, Forms 144 in accordance with Rule 144 of the Securities Exchange Act of 1933, as amended and the rules and regulations thereunder; and (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion. The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934 or Rule 144 of the Securities Act of 1933, as amended. This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 and Forms 144 with respect to the undersigned's holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact. IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 8th day of February, 2011. /s/ John E. Abele John E. Abele -----END PRIVACY-ENHANCED MESSAGE-----